QQQ   348.82 (-1.70%)
AAPL   177.82 (-0.78%)
MSFT   323.38 (-3.09%)
META   263.60 (-2.77%)
GOOGL   122.50 (-3.78%)
AMZN   121.23 (-4.25%)
TSLA   224.57 (+1.47%)
NVDA   374.75 (-3.05%)
NIO   7.76 (-1.52%)
BABA   85.29 (-1.63%)
AMD   117.83 (-5.15%)
T   16.09 (+2.68%)
F   13.59 (+5.11%)
MU   67.06 (-0.71%)
CGC   0.72 (-2.69%)
GE   106.08 (+0.59%)
DIS   92.53 (+0.40%)
AMC   4.73 (+1.94%)
PFE   38.89 (+1.36%)
PYPL   64.04 (-1.51%)
NFLX   399.77 (+0.12%)
QQQ   348.82 (-1.70%)
AAPL   177.82 (-0.78%)
MSFT   323.38 (-3.09%)
META   263.60 (-2.77%)
GOOGL   122.50 (-3.78%)
AMZN   121.23 (-4.25%)
TSLA   224.57 (+1.47%)
NVDA   374.75 (-3.05%)
NIO   7.76 (-1.52%)
BABA   85.29 (-1.63%)
AMD   117.83 (-5.15%)
T   16.09 (+2.68%)
F   13.59 (+5.11%)
MU   67.06 (-0.71%)
CGC   0.72 (-2.69%)
GE   106.08 (+0.59%)
DIS   92.53 (+0.40%)
AMC   4.73 (+1.94%)
PFE   38.89 (+1.36%)
PYPL   64.04 (-1.51%)
NFLX   399.77 (+0.12%)
QQQ   348.82 (-1.70%)
AAPL   177.82 (-0.78%)
MSFT   323.38 (-3.09%)
META   263.60 (-2.77%)
GOOGL   122.50 (-3.78%)
AMZN   121.23 (-4.25%)
TSLA   224.57 (+1.47%)
NVDA   374.75 (-3.05%)
NIO   7.76 (-1.52%)
BABA   85.29 (-1.63%)
AMD   117.83 (-5.15%)
T   16.09 (+2.68%)
F   13.59 (+5.11%)
MU   67.06 (-0.71%)
CGC   0.72 (-2.69%)
GE   106.08 (+0.59%)
DIS   92.53 (+0.40%)
AMC   4.73 (+1.94%)
PFE   38.89 (+1.36%)
PYPL   64.04 (-1.51%)
NFLX   399.77 (+0.12%)
QQQ   348.82 (-1.70%)
AAPL   177.82 (-0.78%)
MSFT   323.38 (-3.09%)
META   263.60 (-2.77%)
GOOGL   122.50 (-3.78%)
AMZN   121.23 (-4.25%)
TSLA   224.57 (+1.47%)
NVDA   374.75 (-3.05%)
NIO   7.76 (-1.52%)
BABA   85.29 (-1.63%)
AMD   117.83 (-5.15%)
T   16.09 (+2.68%)
F   13.59 (+5.11%)
MU   67.06 (-0.71%)
CGC   0.72 (-2.69%)
GE   106.08 (+0.59%)
DIS   92.53 (+0.40%)
AMC   4.73 (+1.94%)
PFE   38.89 (+1.36%)
PYPL   64.04 (-1.51%)
NFLX   399.77 (+0.12%)

ProFrac (PFHC) Stock Forecast, Price & News

$12.18
+0.17 (+1.42%)
(As of 06/7/2023 ET)
Compare
Today's Range
$11.93
$12.42
50-Day Range
$9.44
$22.08
52-Week Range
$13.18
$23.62
Volume
956,811 shs
Average Volume
431,097 shs
Market Capitalization
$1.73 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$27.42

ProFrac MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.86 Rating Score
Upside/​Downside
121.7% Upside
$27.00 Price Target
Short Interest
N/A
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
1.76mentions of ProFrac in the last 14 days
Based on 3 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
40.45%
From $3.14 to $4.41 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.13 out of 5 stars

Oils/Energy Sector

138th out of 243 stocks

Oil & Gas Field Services, Not Elsewhere Classified Industry

10th out of 20 stocks


PFHC stock logo

About ProFrac (NASDAQ:PFHC) Stock

ProFrac Holding Corp., a vertically integrated and energy services company, provides hydraulic fracturing, completion, and other products and services to upstream oil and gas companies engaged in the exploration and production of North American unconventional oil and natural gas resources. It operates through three segments: Stimulation Services, Manufacturing, and Proppant Production. The company also manufactures and sells high horsepower pumps, valves, piping, swivels, large-bore manifold systems, seats, and fluid ends. ProFrac Holding Corp. was founded in 2016 and is headquartered in Willow Park, Texas.

Receive PFHC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ProFrac and its competitors with MarketBeat's FREE daily newsletter.

PFHC Stock News Headlines

PFHC Feb 2023 17.500 call
Sell Every Stock, Except ONE (Ticker Revealed)
We saw one of the longest bull markets in history, with the S&P surging well over 800% But now the chickens have come home to roost. However, Jeff Clark couldn’t care less because he ignores almost every single stock in the market.
Flotek Industries: An Upgrade From The Last Report
The single greatest medical breakthrough of all time?
We are on the cusp of a medical breakthrough. And soon, this single breakthrough could lead to the cure of over 6,000 genetic diseases, including Alzheimer's, heart disease, and even cancer! This reminds me of Amgen, where early investors made as much as 46,751% when they released their revolutionary drug to the market.
ProFrac Holding Corp. Cl A
Analyst Ratings for ProFrac Holding
Earnings Previews: Adobe, ProFrac
Why BofA Believes It's A Good Time To Buy ProFrac
Profrac Holding Corp (PFHC)
See More Headlines

PFHC Price History

PFHC Company Calendar

Today
6/07/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Oil & gas field services, not elsewhere classified
Sub-Industry
N/A
Current Symbol
NASDAQ:PFHC
Fax
N/A
Employees
2,522
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$27.00
High Stock Price Forecast
$31.00
Low Stock Price Forecast
$18.00
Forecasted Upside/Downside
+128.3%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.86
Research Coverage
4 Analysts

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$1.38 billion

Miscellaneous

Free Float
138,711,000
Market Cap
$1.71 billion
Optionable
Not Optionable
Beta
N/A

Key Executives

  • Mr. Matthew D. Wilks (Age 39)
    Exec. Chairman & Pres
    Comp: $248.38k
  • Mr. Ladd Wilks (Age 36)
    Chief Exec. Officer
    Comp: $283.72k
  • Mr. James Coy Randle Jr. (Age 61)
    Chief Operating Officer
    Comp: $357.27k
  • Mr. Robert Willette (Age 46)
    Chief Legal Officer, Chief Compliance Officer & Sec.
    Comp: $119.33k
  • Mr. Lance D. Turner (Age 42)
    Chief Financial Officer
  • Ms. Heather Klein
    Chief Admin. Officer
  • Mr. Jeremy Folmar
    Sr. VP of Sales
  • Mr. Matthew Greenwood
    Chief Commercial Officer
  • Mr. Blaine Wilbanks
    Sr. VP of Operations
  • Mr. Paul Kaster
    Sr. VP of HSE, Compliance & Training













PFHC Stock - Frequently Asked Questions

Should I buy or sell ProFrac stock right now?

4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for ProFrac in the last year. There are currently 1 hold rating and 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" PFHC shares.
View PFHC analyst ratings
or view top-rated stocks.

What is ProFrac's stock price forecast for 2023?

4 Wall Street research analysts have issued 1 year price targets for ProFrac's stock. Their PFHC share price forecasts range from $18.00 to $31.00. On average, they anticipate the company's share price to reach $27.00 in the next year. This suggests a possible upside of 124.8% from the stock's current price.
View analysts price targets for PFHC
or view top-rated stocks among Wall Street analysts.

How have PFHC shares performed in 2023?

ProFrac's stock was trading at $25.20 at the beginning of the year. Since then, PFHC shares have decreased by 52.3% and is now trading at $12.01.
View the best growth stocks for 2023 here
.

When did ProFrac IPO?

(PFHC) raised $360 million in an IPO on Friday, May 13th 2022. The company issued 16,000,000 shares at $21.00-$24.00 per share. J.P. Morgan, Piper Sandler and Morgan Stanley served as the underwriters for the IPO and BofA Securities, Capital One Securities, Johnson Rice & Company, Seaport Global Securities and Stifel were co-managers.

What is ProFrac's stock symbol?

ProFrac trades on the NASDAQ under the ticker symbol "PFHC."

Who are ProFrac's major shareholders?

ProFrac's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Canoe Financial LP (0.68%), Viking Fund Management LLC (0.09%), New York State Common Retirement Fund (0.03%), Virtu Financial LLC (0.03%), Strs Ohio (0.02%) and Inscription Capital LLC (0.02%).

How do I buy shares of ProFrac?

Shares of PFHC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is ProFrac's stock price today?

One share of PFHC stock can currently be purchased for approximately $12.01.

How much money does ProFrac make?

ProFrac (NASDAQ:PFHC) has a market capitalization of $1.71 billion and generates $1.38 billion in revenue each year.

How many employees does ProFrac have?

The company employs 2,522 workers across the globe.

How can I contact ProFrac?

The official website for the company is www.profrac.com. The company can be reached via phone at 254-776-3722 or via email at investors@profrac.com.

This page (NASDAQ:PFHC) was last updated on 6/7/2023 by MarketBeat.com Staff

My Account -